Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Geveko in connection with its new share issue
Mandate

Vinge advises Geveko in connection with its new share issue

February 25, 2010

AB Geveko (publ) has resolved to carry out a new share issue with preferential rights for the shareholders. Through the new issue, which is fully committed and underwritten, the company will raise approximately SEK 160 million excluding transaction costs. The new issue is subject to approval by the extraordinary shareholders’ meeting on 31 March 2010.

AB Geveko is listed on NASDAQ OMX Stockholm.

Vinge’s team consisted primarily of responsible partner Göran Nyström and the associates Anna Björk Larson and Emil Hedberg.

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026

Vinge has advised Resurs in connection with its strategic partnership with Kustom

 Vinge has advised Resurs in connection with its strategic partnership with Kustom (formerly Klarna Checkout), a fast-growing player in the digital commerce sector. The partnership enables Resurs to accelerate its strategic development by offering a check-out solution to its merchants, built on Kustom’s market-leading infrastructure.
March 25, 2026